The Legitimacy of Direct Corporate Humanitarian Investment
The Legitimacy of Direct Corporate Humanitarian Investment
复制标题
直接企业人道主义投资的合法性
作者：
Thomas W. Dunfee;David Hess
翻译后摘要：私营企业具有独特的地位，以提供显着的救济的痛苦，弥漫在发展中国家。由于民族国家和非政府组织在提供救济方面的各种失败，包括腐败和需要援助的国家缺乏强有力的背景机构，全球苦难持续存在。在许多情况下，私营公司在提供援助方面比这些实体具有相对优势。默克公司和治疗河盲症的例子表明，公司如何利用其具体能力和知识，通过直接公司人道主义投资（DCHI）减轻痛苦。DCHI是合法的市场道德，是符合企业在社会中的作用，包括法律的层面。股东可以正式批准公司的DCHI战略，所有利益相关者都可以采取行动支持他们对公司及其DCHI战略的道德愿望。
Abstract: Private firms are uniquely positioned to provide significant relief to the misery that pervades the developing world. Global misery has persisted due to a variety of failures in the provision of relief by nation-states and non-governmental organizations, including corruption and the absence of strong background institutions in the countries in need of aid. In many situations, private firms have a comparative advantage over these entities in the provision of aid. Examples such as Merck and the cure for river blindness show how firms can use their specific competencies and knowledge to relieve misery through Direct Corporate Humanitarian Investment (DCHI). DCHI is legitimized by marketplace morality and is consistent with the role of business within society, including legal dimensions. Shareholders may formally approve a corporation’s DCHI strategy and all stakeholders may act in support of their moral desires with respect to the firm and its DCHI strategy.